Figure 4.
(A) The transcriptional levels of TGF-β1 and TGF-β2 compared with cells treated with CuSO4 and chelators using RT-PCR. (B) The effect of copper with chelators on TGF-β/Smad signaling in GBM cells evaluated by Western blotting assay. (C) Wound healing assays of absence or presence of 40 ng/mL TGF-β1 in 50 μM CuSO4 and images obtained at 48 h. Scale bars: 200 µm. (D) The expression of EMT regulators in GBM cells evaluated using Western blot assay. (E) Measurement of a copper concentration treated with 50 μM CuSO4 with various concentrations of chelators using a copper assay kit. Data represent mean ± SD of three independent experiments using two-tailed t-test. *** p < 0.001.